NK cells expressing interleukin-21 show promising antitumor activity in glioblastoma cells

Published on August 12, 2024

Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like cells (GSCs) both in vitro and in vivo, according to new research.

Read Full Article (External Site)